Rheumatology

Pancreatic Disorders

Questions discussed in this category

What is the role of inebilizumab in the maintenance treatment of IgG4-related disease?

Are there situations when you would choose it over Rituximab?

1 Answer available

How would you manage autoimmune pancreatitis in a patient after Whipple's procedure?

1 Answer available

What is your treatment algorithm for management of retroperitoneal fibrosis that does not respond to high-dose glucocorticoids?

1 Answer available

When would you consider rituximab as induction therapy in IgG4-related disease?

4 Answers available

Would you intensify therapy in IgG4 related disease based solely on a persistently significantly elevated IgG4 level when all disease manifestations and inflammatory markers have normalized?

1 Answer available

How do you approach a patient with IgG4-related disease who has failed rituximab and mycophenolate and continues to rely on high-dose steroids?

The case I am considering involves a patient with biopsy-proven fibrosing dacryoadenitis.

1 Answer available

Papers discussed in this category

Annals of the rheumatic diseases, 2015-06

Rituximab for IgG4-related disease: a prospective, open-label trial.

Neth J Med,

The treatment outcomes in IgG4-related disease.

Medicine (Baltimore),

Therapeutic approach to IgG4-related disease: A systematic review.

Related Topics in Rheumatology